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Abstract
The NTERA2 cl D1 (NT2) cell line, derived from human teratocarcinoma, exhibits similar properties as embryonic stem (ES)
cells or very early neuroepitheial progenitors. NT2 cells can be induced to become postmitotic central nervous system
neurons (NT2N) with retinoic acid. Although neurons derived from pluripotent cells, such as NT2N, have been characterized
for their neurotransmitter phenotypes, their potential suitability as a donor source for neural transplantation also depends
on their ability to respond to localized environmental cues from a specific region of the CNS. Therefore, our study aimed to
characterize the regional transcription factors that define the rostocaudal and dorsoventral identity of NT2N derived from a
monolayer differentiation paradigm using quantitative PCR (qPCR). Purified NT2N mainly expressed both GABAergic and
glutamatergic phenotypes and were electrically active but did not form functional synapses. The presence of immature
astrocytes and possible radial glial cells was noted. The NT2N expressed a regional transcription factor code consistent with
forebrain, hindbrain and spinal cord neural progenitors but showed minimal expression of midbrain phenotypes. In the
dorsoventral plane NT2N expressed both dorsal and ventral neural progenitors. Of major interest was that even under the
influence of retinoic acid, a known caudalization factor, the NT2N population maintained a rostral phenotype subpopulation
which expressed cortical regional transcription factors. It is proposed that understanding the regional differentiation bias of
neurons derived from pluripotent stem cells will facilitate their successful integration into existing neuronal networks within
the CNS.
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Introduction
The field of human embryonic stem (hES) cell research,
although young, holds a potential for advancing our understand-
ing of the mechanisms and pathways of human development and
may provide an unlimited source of human neuronal cells for basic
and applied research, therapeutic drug testing, and tissue repair or
replacement. Yet our current understanding and use of hES cells
for differentiation into neuron and glial subtypes is limited by the
legal, ethical, and political considerations imposed on the use of
these cells as well as the technical aspects of culturing these cells.
Another source of human pluripotent cells is embryonic carcinoma
(EC) cells derived from human male germ cell tumors. Human EC
(hEC) cells resemble hES cells in antigen expression patterns,
developmental potential, and global gene expression including common
gene expression patterns for both ‘‘stemness’’ and pluripotency
[1,2,3,4,5,6]. Unlike hES cells, most hEC cells are simple to passage,
do not require feeder support for propagation and do not undergo
spontaneous differentiation. The NTERA-2 cl. D1 (NT2) cell line is one
of the characterized hEC cell lines used as a model system for
differentiation of cells from the neural lineage [for review see [7]]. The
NT2 neurons (NT2N) derived from NT2 cells are post-mitotic polarized
cells that express neurofilaments, generate action potentials and calcium
spikes, express, release, and respond to neurotransmitters. They have
been used as cell grafts for a rat stroke model where they mature and
display functional integration as well as in phase 1 and 2 clinical trials
with stable stroke patients [2,8,9,10,11,12,13,14,15]. Studies have also
reported that NT2 cells are capable of differentiating into astrocytes
[16,17]. Recently, NT2 cells haveb e e nr e p o r t e dt ob ec a p a b l eo f
generating all three germ layers when differentiation was induced by in
vitro generation of embryoid bodies [5].
Neural progenitors carry their positional identity which on further
differentiation defines the phenotype and activity of the neurons
generated. This positional identity makes these progenitors more
responsive to environmental cues for a specific neural region which is
of critical importance in transplantation. Although the type of neuro-
transmitters expressed by NT2N was first investigated by Guillemain
et al. the lack of spatial identity information results in the inability to
determine (for example) if a tyrosine hydroxylase expressing
catecholaminergic neuron is of midbrain, forebrain or hypothalamus
fate [2]. To address this knowledge gap, we performed quanti-
tative gene expression analysis of both NT2 cells and purified NT2N
to quantify the regulation of the expression of transcription factors
which define the regional identities of neural progenitors and neural
neurotransmitter phenotypes following retinoic acid differentiation.
Results
Differentiation of NT2 cells yields neuronal and glial
populations
In order to assess that the characteristic morphological
properties were consistent with their immunocytochemical prop-
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antibodies specific for the undifferentiated progenitor (SSEA3 and nestin),
neuron (b-tubulin III, Tau, MAP2, and synapsin 1), astroglial (GFAP and
S-100b), or oligodendrocyte (CNPase) phenotypes. As seen in Fig. 1A–C,
NT2 cells expressed both SSEA3 and nestin as previously reported [18].
Staining was not seen with the neuron, astroglial or oligodendrocyte
markers (data not shown) with the exception of b-tubulin III (BT3) and
GFAP. BT3 and GFAP were co-expressed mainly in the nucleus with
light staining of the cytoplasm (Fig. 1B). NT2N displayed no staining for
undifferentiated progenitor or oligodendrocyte markers (data not shown)
but did display staining for all of the neuron markers and GFAP (Fig. 1D–
F). GFAP and BT3 were co-expressed and were confined to the
cytoplasm and neurites (Fig. 1D). Also, as seen in Fig. 1D there are a small
number of what appears to be radial glial cells which display only GFAP
staining and a bipolar morphology (one short and one long unbranched
process).
NT2N co-express Tau and MAP2 staining within cell bodies
(Fig. 1E). Since the NT2N were grouped in cell clusters, neural
Figure 1. Marker expression of NTERA2 (NT2) cells and ATRA differentiated NTERA2 neurons (NT2N). NT2 cells (A–C) co-express GFAP
and SSEA3 with GFAP staining confined to the nucleus (A). NT2 cells also co-express GFAP and b-tubulin III (BT3) which are both mainly confined to
the nucleus (B). Nestin with GFAP are co-localized in NT2 cells (C). NT2N assembled themselves into cell clusters which co-expressed GFAP and BT3
found within the cytoplasm and neurites (D). Arrow heads point to cells that appear as radial glia cells which only display GFAP staining (D). NT2N
also express neural markers TAU and MAP2 with MAP2 confined to dendrites (tapering morphology shown by arrow heads) and TAU not displaying
restriction to axons. In merge panel insert shows close-up view of neurite (E). Synapsin 1 staining is seen as punctate along neurite projections co-
expressing BT3 (F). Photomicrographs were obtained at 100X (A–C; scale bar 200 mm) and 200X (D–F; scale bar 100 mm).
doi:10.1371/journal.pone.0016174.g001
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However, MAP2 staining within neural extensions was restricted
to only a subset of all neural extensions (which appear to be
dendrites based on their tapering morphology) emanating from the
clusters whereas Tau staining was present in all neural extensions
(Fig. 1E). Synapsin staining was puntate along the neurites with
lighter staining seen within the neurites and cytoplasm (Fig. 1F).
ATRA differentiated NT2 cells (after mitotic inhibitor treat-
ment but before the purification of NT2N) were stained for GFAP,
S-100b, BT3, and Tau (Fig. 2A–C). This approach allowed for the
examination of both the neuron and non-neuron phenotypes
present in the culture. All cells present in the culture, to some
extent, displayed GFAP staining. This included the cell clusters as
well as large flat apolar cells appearing morphologically like
protoplasmic astrocytes (Fig. 2A) Also, groups of cells, smaller than
the large protoplasmic cells but larger than the neural cells, were
seen displaying fibroblastic multipolar astrocyte-like morphology.
Staining with S-100b revealed that the large protoplasmic cells
and most of the cells within the cell clusters did not express S-100b
(Fig. 2B). Cells that expressed S-100b were the smaller fibroblastic
astroglial-like cells which were also found within the cell clusters.
The S-100b cells did express co-localization with GFAP but did
not co-localize with Tau indicating the presence of astrocytes
(Figure 2B–C).
NT2N discharge action potentials
To confirm that the NT2 neurons possess the intrinsic electrical
excitability characteristic of neurons, whole-cell patch clamp
recordings were obtained from these cells after 2–3 weeks in
neuron purified culture. Under the current-clamp configuration,
intracellular current injections were applied from the resting
membrane potential, which averaged 261.960.4 mV (n=4).
This evoked a tonic pattern of action potential (AP) discharge in all
cells examined (Fig. 3), with a mean AP amplitude of
48.565.6 mV and a threshold of 226.961.3 mV. The minimum
current intensity needed to elicit AP discharge (i.e. rheobase) was
27.568.5 pA.
To investigate whether the purified neurons establish functional
synaptic contacts voltage-clamp recordings were used to examine
the prevalence of spontaneous excitatory and inhibitory postsyn-
aptic currents (sEPSCs and sIPSCs, respectively). Despite the
presence of an extensive network of neuronal processes, we failed
to observe sEPSCs or sIPSCs in any of the sampled cells (n=10),
suggesting that the in vitro environment was insufficient to promote
synaptogenesis despite clearly promoting neural differentiation.
‘‘Stemness’’, dermal layer, phenotype specific, and
growth factor expression
The transcriptional regulation of ES cell self-renewal and
differentiation involves transcription factors POU class 5 homeo-
box 1 (POU5F1; Oct3/4), Nanog homeobox (NANOG) and sex
determining region Y-box 2 (Sox2) [19]. Down regulation of these
genes removes repression of the differentiation genes and allows
the ES cells to differentiate. NT2 cells expressed all three genes
with NANOG and SOX2 displaying a much higher level of
expression compared with POU5F1 (Fig. 4A). Upon differentia-
tion with ATRA, the resulting NT2N expressed a significant
down-regulation of NANOG (-71 fold change) and POU5F1 (-8-
fold).
Since NT2 cells have been reported to be capable of
differentiating into all three dermal layers expression of endoder-
mal (GATA binding protein 4; GATA4), mesodermal (brachyury
homolog; T) and ectodermal (nestin; NES) markers were
investigated. NT2 cells expressed all 3 dermal markers with the
expression of T an order of magnitude greater than NES which
was higher than GATA4. NT2N also expressed all 3 genes with
only NES being up-regulated (9-fold) and GATA4 and T
undergoing down-regulation (-9 and -34-fold respectively).
To confirm the presence of radial glial (RG) cells, we examined
the expression of phenotype markers fatty acid binding protein 7
(FABP7) and SLC1A3 (EAAT1/GLAST) which known to be
found in this population [20,21]. Both FABP7 and SLC1A3
mRNA was expressed in the NT2 cells. FABP7 was up-regulated
in NT2N (13.7-fold), with no significant change seen in SLC1A3
expression (Fig. 4A), suggesting the maintained presence of or an
increase in the RG cell population. In addition, the expression of
GFAP and BT3 (TUBB3) were investigated in order validate the
previous immunocytochemical findings (Fig. 1). Expression of
GFAP was seen in NT2 cells which was up-regulated (207-fold) in
NT2N (Fig. 4A), consistent with the increase in GFAP staining
seen within this cell population. NT2 cells expressed TUBB3 at a
level just below that seen for the average expression of the
housekeeping genes which was up-regulated in NT2N (4-fold).
Due to the ability of NT2 cells to proliferate in the absence of
feeder cells or the addition of growth factors we examined the
expression of fibroblast growth factor 2 (FGF2; b-FGF) and
epidermal growth factor (EGF) expression. EGF and FGF2 have
been reported to be necessary to maintain pluripotency of hES
cells [22]. NT2 cells expressed both EGF and FGF2 which were
maintained for EGF and up-regulated for FGF2 (4-fold) in NT2N.
Figure 2. Cell types following all-trans-retinoic acid differentiation of NTera2 cells before purification of neurons. Large protoplasmic
astrocytes-like cells that form the basal layer of cells that NTera2 neurons rest on display weak GFAP staining (A). Neural cluster which contains
multipolar fibrous astrocytes which co-express GFAP and S-100b (B). The fibrous astrocytes do not display co-expression of S-100b with b-tubulin III
positive neurons (C). Photomicrographs were obtained at 100X (A; scale bar 200 mm) and 400X (B–C; scale bar 50 mm).
doi:10.1371/journal.pone.0016174.g002
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Consistent with the neural morphology, NT2N have been
reported to express a variety of neurotransmitter phenotypes [2].
This current investigation focused on the expression of GABAer-
gic, glutamatergic, catecholaminergic, and cholinergic phenotypes.
Glutamic acid decarboxylase 65 (GAD65) and glutamic acid
decarboxylase 67 (GAD67) are encoded by GAD2 and GAD1-67
respectively. These two enzymes are responsible for the synthesis
of c-aminobutyric acid (GABA). GAD1 contains two alternative
splice variants yielding GAD 25 and GAD44 [23]. GAD25 is
abundant during early developmental stages but is also present in
the adult brain in regions that undergo continuous synaptic
rearrangements [23,24]. This study focused on GAD1-25, GAD2,
and GAD1-67 since GAD44 is detected only later in development
[23]. All three isoforms were expressed in NT2 cells with GAD1-
67 and GAD2 at much lower expression than GAD1-25. NT2N
expressed all three isoforms with GAD2 and GAD1-25 displaying
no significant change and GAD1-67 significantly up-regulated (9-
fold) (see Fig. 4B).
Vesicular glutamate transporter (VGLUT) confers glutamate
uptake activity to synaptic vesicles. Three isoforms are present
VGLUT 1/2/3 encoded by SLC17A7/A6/A8. VGLUT1 and
VGLUT2 are segregated in the brain and expressed in presynaptic
terminals revealing functional glutamatergic synapse. VGLUT3 is
expressed in presynaptic terminals not classically accepted as
glutamatergic [25,26]. VGLUT1 and 2 were studied here due to
their specificity for glutamatergic neurons. NT2 cells expressed
both SLC17A6 and SLC17A7 with SLC17A7 displaying a much
lower level than SLC17A6 (Fig. 4B). NT2N expressed both
isoforms studied here with only SLC17A7 (VGLUT1) displaying a
significant increase (74-fold).
Tyrosine hydroxylase (TH) is the enzyme responsible for the
synthesis of dopamine and is present in all catecholaminergic
neurons. NT2 cells expressed TH which displayed a significant
increase (5-fold) in NT2N (Fig. 4B).
Choline acetyltransferase (ChAT) is the rate-limiting enzyme in
the synthesis of acetylcholine and the most specific indicator of
cholinergic neurons. NT2 cells expressed ChAT which was
significantly increased (12-fold) in NT2N (Fig. 4B).
Region-Specific Regulatory Gene Expression
Determination of the regional-specific regulatory genes expressed
by NT2N cells was undertaken to determine if in vitro differentiation
of NT2 cells by ATRA led to the establishment of multiple regional
or specific area neural markers of the CNS. NT2N have been
intensively studied but the regional differentiation of these cells has
not been investigated. Due to the use of ATRA one would expect a
caudalization effect to occur yielding neurons of posterior hindbrain
and spinal cord fates [27]. The transcriptional markers used in this
study were all expressed in NT2 cells with the exception of NK2
homeobox 2 (NKX2-2). NKN2-2 was not consistently expressed in
all passages of NT2 cells and when expressed resulted in a Ct of 40
or greater (data not given). Within the NT2N population NKX2-2
could not be detected.
Figure 5 shows the relative expression of regional specific
transcription factor genes along the rostocaudal axis. Of the
rostocaudal markers studied here forebrain makers forkhead box
G1 (FOXG1), and empty spiracles homolog 2 (EMX2) were up-
regulated (2-fold and 10-fold respectively) with LIM homeobox 2
(LHX2) and forebrain midbrain marker orthodenticle homeobox 2
(OTX2) significantly down-regulated (-3-fold and -67-fold respec-
tively). Of the midbrain-hindbrain markers studied engrailed
homeobox 1(EN1), engrailed homeobox 2 (EN2) and paired box 2
(PAX2) were up-regulated (23-fold, 11-fold, and 3-fold respectively)
with GS homeobox 2 (GSX2) and NK2 homeobox 1 (NKX2-1)
displaying no significant change in their expression. Anterior
hindbrain markers gastrulation brain homeobox 2 (GBX2) and
rhombomeric maker early growth response 2 (EGR2; Krox20) were
down regulated (both by -4-fold) with homeobox (HOX) genes
HOXB2, HOXA1, HOXD3, and HOXB6 all displaying up-
regulation (6-fold, 3-fold, 10-fold, and 34-fold respectively). The
transcriptional factor code expressed by the NT2N population would
indicate the presence of progenitors from the forebrain, hindbrain
and spinal cord with little presence of midbrain progenitors.
Figure 6 shows the relative expression of regional specific
transcription factor genes in the dorsoventral axis for telencepha-
lon-related (Fig. 6A) and spinal cord-related genes (Fig. 6B). It should
be noted that some overlap in the two groups exists because genes
such as paired box 6 (PAX6) are expressed in multiple CNS regions
and the NT2 cellsgenerate a mixed population of neural progenitors.
The dorsal telencephalon transcription factors neurogenin 2
(NGN2), EMX2, and PAX6 as well as ventral transcription factors
distal-less homeobox 2 (DLX2) and achaete-scute complex
homolog 1 (ASCL1; Mash1) were up-regulated (6-fold, 10-fold,
71-fold, and 3-fold respectively) in the NT2N population (Fig. 6A).
Telencephalonic ventral markers GSX2 and NKX2-1 showed no
significant change while dorsal marker neurogenin 1 (NGN1)
expression could not be detected in NT2N.
Figure 3. Electrical activity of retinoic acid-differentiated
NTERA2 neurons. Representative traces from a cell exhibiting a tonic
pattern of action potential discharge in response to direct current
injections of 10 pA (top) to 40 pA (10 pA steps; 1 sec duration) from
the resting membrane potential.
doi:10.1371/journal.pone.0016174.g003
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were up-regulated (6-fold and 3-fold respectively), while atonal
homolog 1 (ATOH1; Math1) and paired box 7 (PAX7) showed no
significant change and paired box 3 (PAX3) and NGN1 were
down-regulated (-7-fold and not detected respectively). The ventral
spinal cord transcription factors developing brain homeobox 2
(DBX2) and paired box 6 (PAX6) were up-regulated (17-fold and
71-fold respectively), developing brain homeobox 1 (DBX1), NK6
homeobox 1 (NKX6-1), and oligodendrocyte lineage transcription
factor 2 (OLIG2) showed no significant change, and Iroquois
homeobox 3 (IRX3) was down-regulated (-7-fold) within the
NT2N population. The transcriptional factor code expressed by
the NT2N population represents the presence of both dorsal and
ventral progenitors that are found within the telencephalon and
spinal cord. The data however, does not imply that all progenitor
types found in these two regions of the CNS are present.
Discussion
While it has been clearly established that NT2 cells can
differentiate along the neural ectodermal pathway into postmitotic
neurons after exposure to ATRA, our study is the first to attempt to
characterize the positional identity expressed by this population of
NT2N [8,28,29,30,31,32,33]. The results of this study demonstrate
that under monolayer culture conditions NT2 cells differentiate into
GABAergic and glutamatergic neurons expressing transcription
factors typically observed in the dorsal and ventral forebrain,
hindbrain, and spinal cord. Remarkably, NT2N maintain a rostral
subpopulation of neurons even after differentiation in the presence of
the caudalization influence of RA. Given that culture paradigms are
able to alter the neurotransmitter phenotypes expressed by hESCand
NT2 cells, we further characterized the resultant neurons [34,35,36].
We found that NT2N express neurotransmitter phenotypes that are
consistent with previous reports and are electrically active but are
immature since they do not form functional synapses. Also, the
presence of astrocytes and possible radial glia was noted with no
indication of the presence of oligodendrocytes.
Regional specification of NT2N
Analysis of the expression of regional specific transcription
factors along the rostocaudal axis revealed that NT2 cells,
Figure 4. Relative mRNA expression of cell marker genes and neurotransmitter related genes expressed by NTERA2 (NT2) and
NTERA2 all-trans retinoic acid differentiated neurons (NT2N). Relative amount of mRNA normalized to the average of 3 reference genes
(G3PDH, PPIA, and NUBP1). Relative amount of mRNA for NT2 (black bar) and NT2N (gray bars) were obtained from 6 passage matched cultures
(ranging from 25–36) and all samples were analyzed independently in triplicate. Panel A displays the expression of ‘stemness’, dermal layer, cell type
makers, and growth factor genes. Panel B displays the relative expression of neurotransmitter related genes. All data are expressed as the average
relative gene expression + SEM. For the comparison of NT2 to NT2N:
# p,0.05,
%,p ,0.01, and
& p,0.005.
doi:10.1371/journal.pone.0016174.g004
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show high expression levels of OTX2 and LHX2 (relative mRNA
levels .10
3) indicating the presence of anterior genes mainly of
cortical fates. These cells also highly expressed PAX2, GBX2,
EGR2, HOXB2, and HOXA1 which are characteristic of
hindbrain fates as well as rhombomeric marker EGR2 (Krox20).
More caudal markers HOXD3, and HOXB6 were detected in
decreasing amounts again consistent with hindbrain fates.
Expression of midbrain markers did not rise to this level of
expression. This transcription code would indicate that both
forebrain and hindbrain fates are present within the population of
NT2 cells, suggesting that NT2 cells express an early neuroepi-
thelial stem cell population similar to that reported for neural
rosettes [37]. Since NT2 cells have been reported not to undergo
spontaneous differentiation, unlike ES cells, the presence of
hindbrain transcription factors may be due to the caudalizing
effect of the culture environment as suggested by the high
expression of FGF2 seen here [38].
NT2N transcription factor code indicates the presence of
forebrain, hindbrain, and spinal cord transcriptional markers. Due
to the use of ATRA one would expect a caudalization effect to
occur yielding neurons of the posterior hindbrain and spinal cord
fates. This is seen with the NT2N population with a movement
towards the expression of a more caudal hindbrain fate and the
up-regulation of genes of the spinal cord fate. However, this occurs
without the loss of cortical fates. The known caudalization effect of
RA is somehow resisted by the neural progenitors of this cell
population. One possibility is that RA induces the expression of
PAX6 [39]. In the E10 mouse, when the neural tube is undergoing
regionalization, PAX6 is expressed in forebrain, hindbrain and
spinal cord which concur with the neural fates seen in the NT2N
population [40]. PAX6 is able in a context-dependent manner to
either promote neuroepithelial proliferation or differentiation and
its loss results in a 50% reduction of RG and cortical neurons [41].
Therefore, PAX6 may maintain proliferation of a subpopulation
of cells which continually provide new neural precursors which
maintains the rostral fate seen within the NT2N population. In
addition to PAX6, the high expression of NANOG even after
differentiation with ATRA may also contribute to the resistance of
NT2 cells to either caudalize or undergo differentiation given that
the high expression of NANOG suppresses the differentiation of
ESCs by RA [42].
Rostocaudal patterning of the neural ectoderm initially occurs
in the late blastula through gastrula stages [43] It has been
reported that the presumptive rostral neural ectoderm expresses
CYP26, from the late blastula onwards, which encodes retinoic
acid 4-hydroxylase which specifically degrades RA. The earliest
known marker for caudal ectoderm is HOXB1b which is
expressed in early gastrula and displays a complimentary pattern
to CYP26 [44]. Kudoh et al. have hypothesized that caudalization
occurs by suppression of rostral fates in a two-step process [43].
The first step appears to be regulated by FGFs and WNTs which
down-regulates CYP26, followed by up-regulation of caudal genes
by RA. This would suggest that in order for the rostral population
to survive caudalization CYP26 expression needs to be main-
tained. The NT2 cell population is not homogeneous as evidenced
by their expression of rostocaudal genes as presented here.
Therefore, a population of rostral progenitors is contained within
this population that upon addition of RA is able to maintain itself
without being caudalized. We would propose that the rostral
population of progenitors would express CYP26. Previous work
has shown that there is an antagonism between FGF and RA
signaling in controlling neural differentiation [45]. We have shown
that FGF2 is expressed in NT2 cells and is further up-regulated in
the purified NT2N population which would suggest that other
FGFs and possibly other classes of morphogens are expressed
Figure 5. Relative mRNA expression of regional specific transcription factor genes in the rostocaudal direction for NTERA2 (NT2)
cells and purified NTERA2 all-trans retinoic acid differentiated neurons (NT2N). Relative amount of mRNA normalized to the average of 3
reference genes (G3PDH, PPIA, and NUBP1). Relative amounts of mRNA for NT2 (black bar) and NT2N (gray bars) were obtained from 6 passage
matched cultures (ranging from 25–36) and all samples were analyzed independently in triplicate. Genes are given from rostral to caudal direction
(left to right). Dashed lines divide genes for the forebrain, midbrain, hindbrain, and spinal cord. All data are expressed as the average relative gene
expression + SEM. For the comparison of NT2 to NT2N:
# p,0.05,
% p,0.01, and
& p,0.005.
doi:10.1371/journal.pone.0016174.g005
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of CYP26 and as studied here is added exogenously, in a
concentration much higher than physiological, these rostral
progenitors should be able to resist FGFs and/or WNTs down-
regulation influence on CYP26 and, therefore, resist caudalization
[46].
The transcription factors expressed in the forebrain displayed
an up-regulation or no change in their expression in the NT2N
population with the exception of OTX2 and LHX2. The down-
regulation of LHX2 still results in very high level of expression and
therefore;, would maintain the expression of cortical fates. The
very low level of OTX2 expression seen here could indicate a
movement away from the rostral fate. OTX2 is widely expressed
throughout the forebrain and midbrain where it defines areas of
the rostral brain of E8-E10 mouse embryos. However, starting
from E10.75 OTX2 expression in the murine cerebral cortex
Figure 6. Relative mRNA expression of regional specific transcription factor genes in the dorsoventral direction for NTERA2 (NT2)
cells and purified NTERA2 all-trans retinoic acid differentiated neurons (NT2N). Relative amounts of mRNA normalized to the average of 3
reference genes (G3PDH, PPIA, and NUBP1). Relative amount of mRNA for NT2 (black bar) and NT2N (gray bars) were obtained from 6 passage
matched cultures (ranging from 25–36) and all samples were analyzed independently in triplicate. Panel A displays the relative expression from the
telencephalon and panel B from the spinal cord in a dorsal to ventral order. Dashed line divide dorsal and ventral genes. All data are expressed as the
average relative gene expression + SEM. For the comparison of NT2 to NT2N:
# p,0.05,
%,p ,0.01, and
& p,0.005.
doi:10.1371/journal.pone.0016174.g006
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[47]. This would suggest that the loss in the expression of OTX2
seen in the NT2N population is not necessarily a movement to a
more caudal fate but just the normal loss of OTX2 during
neurogenesis.
In the dorsoventral axis the expression of regional transcription
factors needs to be considered in respect to the rostocaudal region.
As a result the dorsoventral transcription factors were evaluated
separately for the telencephalon and the spinal cord. NT2 cells
express all telencephalonic transcription factors studied here with
high expression being seen in ventral (subpallial) factors DLX2
and ASCL1. DLX2 and ASCL1 are expressed in both the lateral
and medial ganglionic eminences (LGE and MGE) in vivo which
give rise to GABAergic cortical interneurons and cholinergic
telencephalic neurons [48]. DLX2 has been show to induce
GAD1-67 [49]. However, within the MGE, NKX2-1 controls the
development of both telencephalic cholinergic neurons and
GABAergic cortical interneurons and its removal results in a loss
of 50% of the GABAergic interneurons and a total loss of
cholinergic neurons [48]. The weak expression of NKX2-1 in
NT2 cells would thus predict a reduced development of
cholinergic neurons which is consistent with the high expression
of GAD and the very low expression of CHAT seen in the NT2
cell population.
The NT2N population displays an up-regulation of DLX2 and
ASCL1 and no change in NKX2.1 expression. This suggests that
the same ventral fate seen in NT2 cells is present within the NT2N
population. Up-regulation of the genes responsible for the dorsal
telencephalon progenitors is seen following ATRA differentiation.
However, the expression of NGN1 is undetectable. NGN2 is a
downstream target for PAX6 and its up-regulation is most likely a
direct result of PAX6 expression [50]. In NT2 cells RA has been
reported to up-regulate NGN1 throughout the 21 days of the
ATRA differentiation [30]. It appears that the loss of NGN1
expression may be due to the removal of ATRA or that the use of
the mitotic inhibitors may have removed the population of NGN1
expressing progenitors. Up-regulation of NGN2, EMX2, and
PAX6 define the dorsal telencephalon by inhibiting expression of
ventral markers. This leads to the development of glutamatergic
projection neurons (pyramidal). Pyramidal neurons preferentially
express SLC17A7 (VGLUT1) [51]. The development of pyrami-
dal neurons is consistent with the up-regulation of SLC17A7 and
no change in the expression of SLC17A6 seen in the NT2N
population.
NT2 cells express all of the spinal cord dorsoventral axis
transcription factors studied here with high expression of ASCL1,
PAX3, PAX7, NKX6.1, and OLIG2 indicating the present of
both dorsal and ventral neural progenitors. Given the expression
of transcription factors expressed in NT2 cells the intermediate
progenitor domains of ventral progenitor 0 (vp0), and vp1 and the
most ventral domain vp3 are poorly expressed or lacking.
Following exposure of NT2 cells to ATRA the NT2N
population expresses nearly the same progenitor populations as
expressed in NT2 cells. NKX2.2 expression is totally absent
following ATRA and would suggest the absence of vp3
progenitors. The expression of OLIG2 would suggest the possible
development of motor neurons which requires the association of
OLIG2 with NGN2. However, the development of oligodendro-
cytes requires the interaction of OLIG2 with NKX2-2. Since
NKX2-2 is undetectable in the NT2N population the lack of
oligodendrocyte development seen in this population is consistent
with the loss of NKX2.2 expression [52,53]. An increase in the
progenitor population from vp0, and vp1 is seen with the NT2N
population due to the up-regulation of DBX2 which is consistent
with the reported dependence of these progenitor regions on RA
for their development [54].
Neuronal characterization of NT2 cells and NT2N
NT2N described here appear to be immature due to the lack of
restriction of TAU to axons and their lack of formation of
functional synapses. The punctate staining seen with Synapsin 1
has been previously reported to occur in NT2N cultured with or
without astrocytes [12,29]. Here we report that the NT2N possess
intrinsic electrical excitability characteristic of neurons but fail to
establish functional synaptic contacts despite their extensive
network of neural processes. This result appears to be in
agreement with previous reports that the NT2N as well as other
neurons generated from hES cell require cell contact with mature
astrocytes in order to induce synaptogenesis [12,55].
The presence of different neurotransmitter phenotypes has been
previously reported for both monolayer [2] and aggregate
differentiation methods [29]. In agreement with previous reports,
the population of NT2N characterized here displayed up-
regulation of genes directly linked to the GABAergic, glutamater-
gic, catecholaminergic, and cholinergic phenotypes.
We also report the presence of astrocytes in the ATRA-
differentiated cell population before isolation of NT2N and within
the cell clusters present in the purified NT2N population. The
generation of oligodendrocytes, was not seen. This may be due to
the inability of NT2 cells to differentiate into oligodendrocytes, as
supported by the lack of NKX2-2 expression, and is agreement
with other studies using human neurospheres or hES cell lines
[56,57].
As expected, significant down-regulation of the ‘‘stemness’’
genes NANOG and POU5F1 was observed although SOX2
expression was maintained. This finding is in agreement with
previous work [58]. Upon examination of dermal markers
expressed by NT2 cells endodermal, mesodermal, and ectodermal
markers were all present. However, only the ectodermal marker
was up-regulated in response to ATRA triggered differentiation
while both endodermal and mesodermal markers were down-
regulated. This result is consistent with the maintained SOX2
levels forcing the differentiation of ES cells along the ectodermal
differentiation pathway at the expense of endodermal and
mesodermal cell fate [58].
Immunocytochemical analysis of the NT2 and NT2N cell
populations did display some differences from what has been
previously reported for these cells [29,32,57,59]. The NT2 and
NT2N cells displayed co-localized staining for both GFAP and
BT3 which was confirmed by the expression of both BT3
(TUBB3) and GFAP (GFAP) mRNA. GFAP staining of BT3
+
neurons has been previously reported in vitro and was attributed to
the presence of serum-containing medium [60]. The presence of
serum used here to maintain NT2N could account for the co-
localization of BT3 and GFAP. BT3 staining of undifferentiated
NT2 cells is consistent with the reported BT3 staining of
undifferentiated hES cell lines [57]. The expression of GFAP in
NT2 cells is surprising but may be accounted for by the fact that
these cells were derived from an adult in contrast to hES cells
derivation from the blastocyst. Human adult neural stem cells
within the subventricular zone display GFAP [61]. EC cells are
derived from carcinoma in situ (CIS) cells showing high similarity
to primordial germ cell/gonocytes, which through a process of
adaptation undergo dedifferentiation to become EC cells [62,63].
Since NT2 cells are EC cells which are derived from a restricted
embryonic/neonatal precursor cell developed in an adult niche
one might hypothesize that expression of GFAP in theses adult-
derived cancerous stem cells may occur. However, in the human
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nestin is seen in the telencephalic VZ/SVZ at the ganglionic
eminence and the developing cortical plate [64]. This correlates
with the expression of these three genes at both the protein and
mRNA levels in NT2 cells and may indicate that NT2 cells express
an early neural progenitor phenotype as previously reported by
Pleasure et al [59]. This correlates with the expression of these
three genes at both the protein and mRNA levels in NT2 cells.
This expression pattern combined with the expression of FABP7
and SLC1A3 are consistent with human RG or neural precursor
cells [21]. Based on their bipolar morphology RG cells appear to
be present within the cell clusters of the NT2N population which is
consistent with the differentiation pathway seen during both in vivo
and in vitro differentiation of hESC [35,65,66,67].
Unlike hES cells, NT2 cells do not require either the use of
feeder cells or the addition of FGF2 and EGF. The high expression
level of NANOG may account for the ability of NT2 cells to grow
well in the absence of feeder cells as has been reported for hES
cells expressing high levels of NANOG [68]. Furthermore, human
EC cells have been reported to produce FGF2 [69,70]. We have
confirmed that NT2 cells express FGF2 as well as EGF mRNA. If
the expression of mRNA for both FGF2 and EGF translate into
protein expression, as reported for FGF2, this may also account for
the ability of NT2 cells to self-replicate without the need for feeder
cells or additional growth factors.
Conclusion
Given the transcription factor code expressed by NT2 cells and
NT2N it appears that NT2 cells under the paradigm studied here
are restricted to areas of PAX6 expression, namely the forebrain,
hindbrain, and spinal cord, yielding both dorsal and ventral
progenitors from these areas. This restricted transcriptional code
resulted in both glutamatergic and GABAergic neurotransmitter
phenotypes from these regions which contrasts with the preferential
GABAergic phenotype seen inlong-term expanded primaryand ES
cell derived neural precursors [71,72]. The maintained expression
ofa rostral precursorpopulationinthepresenceofboth endogenous
and exogenous caudalization factors is a surprise and the relevant
underlying mechanism remains unclear. It can be hypothesized that
the total NT2cell populationdoes not undergodifferentiation at the
same rate and even under the influences of growth factors and/or
morphogens a population of early neural progenitors is maintained
possibly through the high expression of PAX6 and/or NANOG.
This may be a condition of the EC cell malignant state. Yet this cell
line provides both a model of human neural cell differentiation and
a source of a diverse population of human central nervous system
neurons which are amenable to further study. Given that NT2N
cells have been used for phase 1 and 2 clinical trials in stable stroke
patients and to date (10 and 5 years after publication of the trials
respectively) transplanted NT2N have demonstrated consistent
non-tumorigenic outcomes and are as efficacious as human fetal
cells, these neurons may be cautiously viewed as useful for
therapeutic use [15]. Understanding the regional specification of
the neurons derived from pluripotent stem cells may facilitate their
integration and aid the design of effective strategies for neural
transplantation within the CNS.
Materials and Methods
Cell Culture
NTERA-2 cl.D1 (NT2) cells were obtained from American
Type Culture Collection (CRL-1973; Manassas, VA) and
maintained in Dulbecco’s modified Eagle’s medium (high glucose)
containing 10% fetal bovine serum (FBS), 2 mM L-alanyl-L-
glutamine (AG), 25 mM HEPES buffer (pH7.3), 1X minimum
essential medium non-essential amino acids, 56 mM b-mercapto-
ethanol (b-ME), and 25 mg/ml gentamicin sulfate (GS). The cells
were fed twice a week and split 1:4 when confluent by mechanical
scraping. For differentiation with retinoic acid NT2 cells were
trypsinized with 0.05% trypsin/EDTA and plated at
2.7610
4cells/cm
2 in Opti-MEM I (Invitrogen; Carlsbad, CA)
containing 4% FBS, 2 mM AG, 56 mM bME, 25 mg/ml GS, and
10 mM all-trans retinoic acid (ATRA; Sigma-Aldrich, St. Louis).
Cell were fed twice a week for four weeks and the neurons were
isolated in accordance with Pleasure et al. [8]. Briefly, following
ATRA differentiation, cells were replated at 1:6. After 1–2 days
cultures were mechanically shaken to dislodge cells and these free-
floating cells were plated onto poly-L-ornithine (PLO)/Matrigel or
Geltrex coated growth surface in Opti-MEM I containing 4%
FBS, 2 mM AG, 56 mM bME, 25 mg/ml GS, 1 mM cytosine
arabinoside, 10 mM fluorodexoyuridine, and 10 mM uridine.
Cells were fed twice a week for four weeks. Following this
treatment, purified neurons were isolated by mechanically
dislodging the neurons from the basal layer of cells and replated
on PLO/Matrigel or Geltrex in the same media without cytosine
arabinoside, fluorodexoyuridine, or uridine.
Antibodies and Immunofluorescence
For immunofluorescence NT2 cells or purified ATRA differenti-
ated NT2 cell derived neurons (NT2/N) were grown on 12 mm glass
coverslips coated with poly-L-ornithine (PLO; Sigma)/Matragel
(Becton Dickerson) and washed with phosphate buffered saline (PBS,
pH 7.2). The cells were then fixed for 20 min in 4% paraformal-
dehyde and 4% sucrose in PBS. The cells were then washed 2X with
P B Sa n dp e r m e a b i l i z e df o r2 0m i nw i t h0 . 3 %T r i t o nX - 1 0 0i nP B S .
The cells were then washed with PBS and blocked for 1 hr with 1%
bovine serum albumin in PBS. The cells were then incubated for 2 hr
with the primary antibody at the listed dilutions in PBS. Following
primary antibody incubation the cells were washed 3X with PBS and
incubated with the appropriate secondary antibody for 1 hr in PBS.
Following washing 3X in PBS the coverslips were mounted for
microscopy in Vectashield hard-set mounting medium (Vector
Laboratories, Burlingame, CA). Images were acquired using a Nikon
Microphot-SA microscope with a SensiCam cooled CCD camera
(Cooke Corp., Eugene, OR) and using CamWare image acquisition
software (Ver 2.13, Cooke Corp.).
Anti-human stage specific embryonic antigen 3 (SSEA3) (sc-
21703, Santa Cruz Biotechnology, CA), anti-tubulin, beta III
isoform (MAB1637, Chemicon International), and anti-29,39-
cyclic nucleotide 39-phosphodiesterase (CNPase) monoclonal
antibodies (C 5922, Sigma-Aldrich) were used at a dilution of
1:50. Anti-nestin monoclonal human specific antibody (MAB5326,
Millipore), anti-microtubules associated protein 2 (MAP2) mono-
clonal antibody (13–1500, Invitrogen), anti-TAU polyclonal
antibody (AHB0351, Invitrogen), anti-glial fibrillary acidic protein
(GFAP) IgG purified polyclonal antibody (G 9269, Sigma-
Aldrich), and. anti-synapsin 1 polyclonal antibody (A6442,
Invitrogen) were used at a dilution of 1:200. Fluorescein (FITC)
conjugated goat anti-mouse IgG (115-095-062), FITC-conjugated
goat anti-rat IgM (112-095-075), FITC-conjugated goat anti-
rabbit IgG (111-095-144), Cy3-conjugate goat anti mouse (115-
095-146) and Cy3-conjugated goat anti-rabbit (111-165-144)
(Jackson ImmunoResearch, West Grove, PA) were used at a
dilution of 1:100.
Electrophysiological recordings
Coverslips with NT2N were transferred to a submersion-type
chamber (RC-22; Warner Instruments, Hamden, CT), mounted
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Valley, PA) and perfused at room temperature with oxygenated
artificial CSF (aCSF) solution containing the following (in mM):
125 NaCl, 2.5 KCl, 25 NaHCO3, 1.0 NaH2PO4, 1.0 MgCl2, 2.0
CaCl2, and 25 glucose, at a rate of 1.5–3 ml/min.
Recording electrodes were constructed from thin-walled single-
filamented borosilicate glass (1.5 mm outer diameter; World
Precision Instruments, Sarasota, FL) using a microelectrode puller
(Sutter Instruments, Novato, CA). Pipette resistances ranged from
5t o7M V and seal resistances were .1G V. For voltage-clamp
experiments, patch electrodes were filled with a solution
containing the following (in mM): 130 Cs-gluconate, 10 CsCl,
10 HEPES, 11 EGTA, 1.0 CaCl2, and 2.0 MgATP, pH 7.2 (300–
305 mOsm). EPSCs were isolated at a holding potential (hp) of
270 mV while IPSCs were recorded at a hp of 0 mV, thus
minimizing the contribution of NMDA and AMPA/kainate
receptor-mediated events [73]. Current clamp experiments used
an electrode solution of (mM): 130 potassium gluconate, 10 KCl,
10 Hepes, 1.0 EGTA, 0.1 CaCl2, 2.0 MgATP, pH 7.2 (300–305
mOsm). Neurons were visualized with infrared-differential inter-
ference contrast and whole-cell patch-clamp recordings were
obtained using a Multiclamp 700B amplifier (Molecular Devices,
Sunnyvale, CA). Under the current-clamp configuration, action
potentials were evoked via current injection through the recording
electrode (10–50 pA in 10 pA steps; 1 sec duration).
Membrane voltages were adjusted for liquid junction potentials
(approximately –14 mV) calculated using JPCalc software (P.
Barry, University of New South Wales, Sydney, Australia;
modified for Molecular Devices). Currents were filtered at 4–
6 kHz through a –3 dB, four-pole low-pass Bessel filter, digitally
sampled at 20 kHz, and stored on a personal computer (ICT,
Cincinnati, OH) using a commercially available data acquisition
system (Digidata 1440A with pClamp 10.0 software; Molecular
Devices). All data are expressed as mean 6 SEM.
RNA Isolation and cDNA Preparation
Total RNA was collected from passage matched (ranging from
25–36) NT2 and NT2N cultures (N=6/experiment) following a
HBSS w/o wash. RNA extraction and DNase I treatment were
accomplished using the Absolutely RNA Purification Kit accord-
ing to the manufacturer’s instructions (Stratagene, La Jolla, CA).
The RNA was quantitated using a fluorescence method (Quant-iT
RNA assay Kit and Qubit Fluorometer; Invitrogen). The isolated
RNA was aliquoted and stored at 275uCi n1 0mM Tris-HCl
buffer (pH 8.0) until use. One mg of total RNA per reaction, 4
reactions per sample, were reverse transcribed in a volume of
20 ml, using the iScript cDNA Synthesis Kit (Bio-Rad Laborato-
ries, Hercules, CA) by incubation at 25uC for 10 min, 42uC for
45 min, 85uC for 5 min followed by a hold at 4uC. The first strand
cDNA reaction was stored at 220uC until use.
Oligonucleotide Primers
Primers were designed using Primer-BLAST software which
incorporates Primer3 software to design the primers and a BLAST
search of the primers against a user selected database (Homo
sapiens Refseq RNA database). (www.ncbi.nlm.nih.gov/tools/
primer-blast/) [74]. All primers were designed to allow for specific
amplification of the gene specific mRNA independent of splice
variants (when possible), to anneal at 60uC, and to traverse an
intron boundary (see Supporting Information Table S1). All
amplicons were confirmed by agarose electrophoresis to assess if
the amplicon was the predicted size and a single product. All
oligonucleotides used in this study were synthesized by Operon
Biotechnologies Inc. (Huntsville, AL).
Quantitative RT-PCR
Quantitative RT-PCR (qPCR) was performed on the MPx3005
instrument (Stratagene). Each 25 ml reaction included 12.5 mlo f
DyNAmo HS SYBR Green 2X Master mix (New England
Biolabs, Inc.; Ipswich, MA) containing 2.5 mM MgCl2, 0.3 mM
each forward and reverse primer, 2 mM ROX reference dye, and
25 ng of cDNA. The experiment was performed following the
following protocol: activation of the Taq polymerase at 95uC for
15 min, followed by 45 cycles of denaturing at 95uC for 15 sec,
annealing at 60uC for 1 min, extension at 72uC for 1 min followed
by fluorescence measurement at 516 and 610 nm (SYBER Green
and ROX respectively). This was followed by a melting curve
analysis. All experiments included no-template controls and all
samples were analyzed independently in triplicate. The determi-
nation of PCR efficiency, threshold cycle (Ct) determination, and
RNA starting concentration were calculated using raw fluores-
cence data using LinRegPCR analysis software [75,76].
Statistical Analysis
Groupwise comparison of gene expression ratios was performed
by REST-2009 (December 2009 release) [77]. Expression data
was normalized to the geometric mean of three housekeeping
genes: glyceraldehyde-3-phosphate dehydrogenase (G3PDH),
peptidylprolyl isomerase A (cyclophilin A; PPIA), and nucleotide
binding protein 1 (NUBP1). Randomization was conducted using
6,000 permutations for statistical evaluation. The REST 2009
program incorporates correction for amplification efficiencies (as
determined by LinReg) into the calculation of gene expression
ratios. The level of significance was determined as p,0.05.
Supporting Information
Table S1 Primer sequences and amplicon size.
(DOCX)
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